/600538.SS
600538.SS Stock - Beihai Gofar Chuanshan Biological Co., Ltd.
Basic Materials|Agricultural InputsSHH
$6.35+2.58%
+$0.16 (+2.58%) • Dec 25
72
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.71
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $6.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 600538.SS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.29 – $6.41
TARGET (TP)$7.30
STOP LOSS$5.84
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.17
52W High$6.93
52W Low$4.32
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $340.47M | $369.15M | $459.68M | $424.72M | $267.70M |
| Gross Profit | $87.28M | $89.70M | $126.71M | $109.54M | $67.07M |
| Gross Margin | 25.6% | 24.3% | 27.6% | 25.8% | 25.1% |
| Operating Income | $-91,688,934 | $-77,762,697 | $42.28M | $15.16M | $8.82M |
| Net Income | $-93,850,240 | $-82,308,269 | $34.84M | $10.49M | $3.20M |
| Net Margin | -27.6% | -22.3% | 7.6% | 2.5% | 1.2% |
| EPS | $-0.18 | $-0.16 | $0.07 | $0.02 | $0.01 |
Company Overview
Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eyesight eye drops, gastrointestinal granules, pearl powder, and other proprietary Chinese medicines. It also provides molecular medical imaging and tumor radiotherapy centers, as well as tumor telemedicine technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in May 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was founded in 1993 is based in Beihai, China.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
600538.SSBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.14
Q2 2025
EPS Surprise History
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 16, 2025 | — | $-0.14 | — | — |
Q1 2025 | Mar 31, 2025 | — | $0.01 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.01 | — | — |
Q2 2024 | Jun 30, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 17, 2024 | — | $-0.13 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-0.02 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.03 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.00 | — | — |
Q2 2021 | Apr 27, 2021 | — | $0.02 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 600538.SS
What is 600538.SS's current stock price?
Beihai Gofar Chuanshan Biological Co., Ltd. (600538.SS) is currently trading at $6.35 per share. The stock has moved +2.58% today.
What is the analyst price target for 600538.SS?
No analyst price targets are currently available for this stock.
What sector is Beihai Gofar Chuanshan Biological Co., Ltd. in?
Beihai Gofar Chuanshan Biological Co., Ltd. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the SHH exchange.
What is 600538.SS's market cap?
Beihai Gofar Chuanshan Biological Co., Ltd. has a market capitalization of $3.33 billion, making it a mid-cap company.
Does 600538.SS pay dividends?
No, Beihai Gofar Chuanshan Biological Co., Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Basic Materials Sector000707.SZ
Hubei Shuanghuan Science and Technology Stock Co.,Ltd
$6.18
Mkt Cap: $3.0B
002942.SZ
Zhejiang XinNong Chemical Co.,Ltd.
$20.09
Mkt Cap: $3.1B
003042.SZ
Shandong Sino-Agri United Biotechnology Co.,Ltd.
$16.32
Mkt Cap: $2.3B
300575.SZ
Jiangsu Flag Chemical Industry Co., Ltd.
$5.96
Mkt Cap: $2.8B
600228.SS
Fanli Digital Technology Co.,Ltd
$5.31
Mkt Cap: $2.2B
600257.SS
Dahu Health Industry Co., Ltd.
$6.17
Mkt Cap: $3.0B
600423.SS
Liuzhou Chemical Industry Co., Ltd.
$3.87
Mkt Cap: $3.1B
600470.SS
Anhui Liuguo Chemical Co., Ltd.
$6.13
Mkt Cap: $3.2B
603810.SS
Jiangsu Fengshan Group Co.,Ltd
$16.25
Mkt Cap: $2.7B
605033.SS
Shaanxi Meibang Pharmaceutical Group Co., Ltd.
$19.70
Mkt Cap: $2.7B
Explore stocks similar to 600538.SS for comparison